Literature DB >> 12686539

Quantitative analysis of HER2-mediated effects on HER2 and epidermal growth factor receptor endocytosis: distribution of homo- and heterodimers depends on relative HER2 levels.

Bart S Hendriks1, Lee K Opresko, H Steven Wiley, Douglas Lauffenburger.   

Abstract

Endocytic trafficking plays an important role in the regulation of the epidermal growth factor receptor (EGFR) family. Many cell types express multiple EGFR family members (including EGFR, HER2, HER3, and/or HER4) that interact to form an array of homo- and heterodimers. Differential trafficking of these receptors should strongly affect signaling through this system by changing substrate access and heterodimerization efficiency. Because of the complexity of these dynamic processes, we used a quantitative and computational model to understand their integrated operation. Parameters characterizing EGFR and HER2 interactions were determined using experimental data obtained from mammary epithelial cells constructed to express different levels of HER2, enabling us to estimate receptor-specific internalization rate constants and dimer uncoupling rate constants. Significant novel results obtained from this work are as follows: first, that EGFR homodimerization and EGFR/HER2 heterodimerization occur with comparable affinities; second, that EGFR/HER2 heterodimers traffic as single entities. Furthermore, model predictions of the relationship of HER2 expression levels to consequent distribution of EGFR homodimers and EGFR/HER2 heterodimers suggest that the levels of HER2 found on normal cells are barely at the threshold necessary to drive efficient heterodimerization. Thus, altering HER2 concentrations, either overall or local, could provide an effective mechanism for regulating EGFR/HER2 heterodimerization and may explain why HER2 overexpression found in some cancers has such a profound effect on cell physiology.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12686539     DOI: 10.1074/jbc.M300477200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  75 in total

1.  Association with membrane protrusions makes ErbB2 an internalization-resistant receptor.

Authors:  Anette M Hommelgaard; Mads Lerdrup; Bo van Deurs
Journal:  Mol Biol Cell       Date:  2004-01-23       Impact factor: 4.138

Review 2.  Antibody vectors for imaging.

Authors:  Tove Olafsen; Anna M Wu
Journal:  Semin Nucl Med       Date:  2010-05       Impact factor: 4.446

3.  Ligand accumulation in autocrine cell cultures.

Authors:  Michael I Monine; Alexander M Berezhkovskii; Elizabeth J Joslin; H Steven Wiley; Douglas A Lauffenburger; Stanislav Y Shvartsman
Journal:  Biophys J       Date:  2005-01-14       Impact factor: 4.033

Review 4.  Computational modelling of the receptor-tyrosine-kinase-activated MAPK pathway.

Authors:  Richard J Orton; Oliver E Sturm; Vladislav Vyshemirsky; Muffy Calder; David R Gilbert; Walter Kolch
Journal:  Biochem J       Date:  2005-12-01       Impact factor: 3.857

Review 5.  Mechanisms of tumor resistance to EGFR-targeted therapies.

Authors:  Elizabeth A Hopper-Borge; Rochelle E Nasto; Vladimir Ratushny; Louis M Weiner; Erica A Golemis; Igor Astsaturov
Journal:  Expert Opin Ther Targets       Date:  2009-03       Impact factor: 6.902

6.  Dynamic transition states of ErbB1 phosphorylation predicted by spatial stochastic modeling.

Authors:  Meghan McCabe Pryor; Shalini T Low-Nam; Adám M Halász; Diane S Lidke; Bridget S Wilson; Jeremy S Edwards
Journal:  Biophys J       Date:  2013-09-17       Impact factor: 4.033

Review 7.  The oncogene HER2: its signaling and transforming functions and its role in human cancer pathogenesis.

Authors:  M M Moasser
Journal:  Oncogene       Date:  2007-04-30       Impact factor: 9.867

Review 8.  ERBB3/HER3 and ERBB2/HER2 duet in mammary development and breast cancer.

Authors:  David F Stern
Journal:  J Mammary Gland Biol Neoplasia       Date:  2008-05-03       Impact factor: 2.673

9.  Glypican-3-Specific Antibody Drug Conjugates Targeting Hepatocellular Carcinoma.

Authors:  Ying Fu; Daniel J Urban; Roger R Nani; Yi-Fan Zhang; Nan Li; Haiying Fu; Hamzah Shah; Alexander P Gorka; Rajarshi Guha; Lu Chen; Matthew D Hall; Martin J Schnermann; Mitchell Ho
Journal:  Hepatology       Date:  2019-02-19       Impact factor: 17.425

10.  HER-2-mediated endocytosis of magnetic nanospheres and the implications in cell targeting and particle magnetization.

Authors:  Shy Chyi Wuang; Koon Gee Neoh; En-Tang Kang; Daniel W Pack; Deborah E Leckband
Journal:  Biomaterials       Date:  2008-03-04       Impact factor: 12.479

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.